Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.1 (
ACS
)
78,556
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The threat imposed by the use of psychoactive, illicit drugs on human health and the cost of rehabilitation of the affected individuals is nothing less than billions of dollars per year. Of the
psychoactive substance abuse
drugs are amphetamine and its analogues like methamphetamine. This Viewpoint intends to draw the attention of readers toward the neurological basis of "falling a prey" to methamphetamine. Attention has been paid toward a rapid desensitizing attribute that develops shortly after the repetitive use of drugs belonging to sympathomimetic agents of this group. Also summarized are the changes in physical characteristics and behavioral changes that could herald the loved ones around the methamphetamine abuser to seek the help of healthcare professionals before permanent and irreversible neurological damage ensues. A brief pharmacology of methamphetamine also precedes the management of these patients, for which no standard procedures exist at present.
ACS
Chem Neurosci 2018 10 17
PMID:DARK Side of Amphetamine and Analogues: Pharmacology, Syndromic Manifestation, and Management of Amphetamine Addiction. 2967 82